
Champions Oncology, Inc.
CSBRNasdaqCIK 771856HealthcareFiscal year ends Apr 30
Reports and events: 248 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-03-1515:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-18-003224 |
| 2018-03-1214:26 ET | 8-K | 7.01 Regulation FD disclosure | 0001628280-18-003075 |
| 2017-12-1512:05 ET | 10-Q | Quarterly reportPeriod 2017-10-31 | 0001628280-17-012357 |
| 2017-12-0716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-17-012191 |
| 2017-10-1616:53 ET | 8-K | 5.07 Shareholder vote results | 0001628280-17-009909 |
| 2017-10-0416:21 ET | 8-K | 8.01 Other events | 0001628280-17-009685 |
| 2017-09-1417:22 ET | 10-Q | Quarterly reportPeriod 2017-07-31 | 0001628280-17-009317 |
| 2017-09-1416:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-17-009310 |
| 2017-08-2817:19 ET | DEF 14A | Proxy statementPeriod 2017-04-30 | 0001628280-17-008952 |
| 2017-08-0814:58 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-17-030547 |
| 2017-07-2816:01 ET | 10-K | Annual reportPeriod 2017-04-30 | 0001628280-17-007429 |
| 2017-07-2715:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-17-007345 |
| 2017-05-0915:38 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-17-005232 |
| 2017-04-2814:19 ET | 8-K | 3.01 Delisting notice | 0001628280-17-004475 |
| 2017-03-1713:54 ET | 10-Q | Quarterly reportPeriod 2017-01-31 | 0001628280-17-002681 |
| 2017-03-1616:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-17-002637 |
| 2017-01-2613:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-17-000428 |
| 2017-01-1309:47 ET | SC 13D | Ownership report, active investor | 0001140361-17-001769 |
| 2016-12-1416:05 ET | 10-Q | Quarterly reportPeriod 2016-10-31 | 0001628280-16-022031 |
| 2016-11-2916:15 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001628280-16-021707 |
| 2016-11-0112:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-16-020505 |
| 2016-10-2816:53 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-16-751759 |
| 2016-10-1413:11 ET | 8-K | 5.07 Shareholder vote results | 0001628280-16-020070 |
| 2016-09-1415:07 ET | 10-Q | Quarterly reportPeriod 2016-07-31 | 0001628280-16-019568 |
| 2016-09-0908:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-16-019460 |
| 2016-08-2513:51 ET | DEF 14A | Proxy statementPeriod 2016-10-13 | 0001628280-16-019240 |
| 2016-07-2913:09 ET | 10-K | Annual reportPeriod 2016-04-30 | 0001628280-16-017936 |
| 2016-07-2807:52 ET | 8-K | 9.01 Financial statements and exhibits | 0001628280-16-017853 |
| 2016-07-2216:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-16-017718 |
| 2016-06-1516:32 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-108364 |
| 2016-05-2420:38 ET | S-1/A | Registration statement, amended | 0001144204-16-104317 |
| 2016-05-1817:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-16-103415 |
| 2016-04-2621:01 ET | S-1 | Registration statement | 0001144204-16-096166 |
| 2016-04-1316:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-16-094098 |
| 2016-03-2515:00 ET | 8-K | 3.01 Delisting notice | 0001144204-16-090355 |
| 2016-03-1610:01 ET | 10-Q | Quarterly reportPeriod 2016-01-31 | 0001144204-16-088331 |
| 2016-03-1508:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-16-087998 |
| 2016-03-0717:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-16-086415 |
| 2015-12-1517:21 ET | 10-Q | Quarterly reportPeriod 2015-10-31 | 0001144204-15-071025 |
| 2015-12-1416:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-15-070741 |
| 2015-10-2916:00 ET | 8-K | 3.01 Delisting notice | 0001144204-15-061545 |
| 2015-10-1508:00 ET | 8-K | 5.07 Shareholder vote results | 0001144204-15-059503 |
| 2015-09-1116:02 ET | 10-Q | Quarterly reportPeriod 2015-07-31 | 0001144204-15-054634 |
| 2015-09-1016:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-15-054407 |
| 2015-08-3117:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001144204-15-053058 |
| 2015-08-2817:08 ET | DEF 14A | Proxy statementPeriod 2015-10-13 | 0001144204-15-052769 |
| 2015-08-2110:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-051200 |
| 2015-08-1319:38 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-048660 |
| 2015-07-2916:09 ET | 10-K | Annual reportPeriod 2015-04-30 | 0001144204-15-044834 |
| 2015-07-2808:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001144204-15-044476 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.